These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29856915)

  • 1. FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody-Drug Conjugates.
    Lee BC; Chalouni C; Doll S; Nalle SC; Darwish M; Tsai SP; Kozak KR; Del-Rosario G; Yu SF; Erickson H; Vandlen R
    Bioconjug Chem; 2018 Jul; 29(7):2468-2477. PubMed ID: 29856915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies.
    Kulkarni C; Finley JE; Bessire AJ; Zhong X; Musto S; Graziani EI
    Bioconjug Chem; 2017 Apr; 28(4):1041-1047. PubMed ID: 28191936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systems Pharmacology Model for Drug Delivery to Solid Tumors by Antibody-Drug Conjugates: Implications for Bystander Effects.
    Burton JK; Bottino D; Secomb TW
    AAPS J; 2019 Dec; 22(1):12. PubMed ID: 31828446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.
    Caculitan NG; Dela Cruz Chuh J; Ma Y; Zhang D; Kozak KR; Liu Y; Pillow TH; Sadowsky J; Cheung TK; Phung Q; Haley B; Lee BC; Akita RW; Sliwkowski MX; Polson AG
    Cancer Res; 2017 Dec; 77(24):7027-7037. PubMed ID: 29046337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive ELISA Method for the Measurement of Catabolites of Antibody-Drug Conjugates (ADCs) in Target Cancer Cells.
    Salomon PL; Singh R
    Mol Pharm; 2015 Jun; 12(6):1752-61. PubMed ID: 25738394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Modeling of Antibody-Drug Conjugate Internalization at the Cellular Level Reveals Inefficient Processing Steps.
    Durbin KR; Phipps C; Liao X
    Mol Cancer Ther; 2018 Jun; 17(6):1341-1351. PubMed ID: 29592884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates.
    Mahalingaiah PK; Ciurlionis R; Durbin KR; Yeager RL; Philip BK; Bawa B; Mantena SR; Enright BP; Liguori MJ; Van Vleet TR
    Pharmacol Ther; 2019 Aug; 200():110-125. PubMed ID: 31028836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of Antibody-Drug Conjugates in Cancer Cells.
    Chalouni C; Doll S
    J Exp Clin Cancer Res; 2018 Feb; 37(1):20. PubMed ID: 29409507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of linker stability to the activities of anticancer immunoconjugates.
    Alley SC; Benjamin DR; Jeffrey SC; Okeley NM; Meyer DL; Sanderson RJ; Senter PD
    Bioconjug Chem; 2008 Mar; 19(3):759-65. PubMed ID: 18314937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates.
    Pabst M; McDowell W; Manin A; Kyle A; Camper N; De Juan E; Parekh V; Rudge F; Makwana H; Kantner T; Parekh H; Michelet A; Sheng X; Popa G; Tucker C; Khayrzad F; Pollard D; Kozakowska K; Resende R; Jenkins A; Simoes F; Morris D; Williams P; Badescu G; Baker MP; Bird M; Frigerio M; Godwin A
    J Control Release; 2017 May; 253():160-164. PubMed ID: 28257988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-conjugated drug assay for protease-cleavable antibody-drug conjugates.
    Sanderson RJ; Nicholas ND; Baker Lee C; Hengel SM; Lyon RP; Benjamin DR; Alley SC
    Bioanalysis; 2016; 8(1):55-63. PubMed ID: 26647801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internalization, Trafficking, Intracellular Processing and Actions of Antibody-Drug Conjugates.
    Xu S
    Pharm Res; 2015 Nov; 32(11):3577-83. PubMed ID: 26108878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates.
    Frigerio M; Kyle AF
    Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of bioconjugate therapeutics: why, when, and how?
    Liu H; Bolleddula J; Nichols A; Tang L; Zhao Z; Prakash C
    Drug Metab Rev; 2020 Feb; 52(1):66-124. PubMed ID: 32045530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
    Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates.
    Sun X; Ponte JF; Yoder NC; Laleau R; Coccia J; Lanieri L; Qiu Q; Wu R; Hong E; Bogalhas M; Wang L; Dong L; Setiady Y; Maloney EK; Ab O; Zhang X; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2017 May; 28(5):1371-1381. PubMed ID: 28388844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catabolism of antibody drug conjugates and characterization methods.
    Shadid M; Bowlin S; Bolleddula J
    Bioorg Med Chem; 2017 Jun; 25(12):2933-2945. PubMed ID: 28438386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution, metabolism, and excretion considerations for the development of antibody-drug conjugates.
    Han TH; Zhao B
    Drug Metab Dispos; 2014 Nov; 42(11):1914-20. PubMed ID: 25048520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization.
    Harper J; Mao S; Strout P; Kamal A
    Methods Mol Biol; 2013; 1045():41-9. PubMed ID: 23913140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of trisulfide modification of antibodies on the properties of antibody-drug conjugates manufactured using thiol chemistry.
    Liu R; Chen X; Dushime J; Bogalhas M; Lazar AC; Ryll T; Wang L
    MAbs; 2017 Apr; 9(3):490-497. PubMed ID: 28136017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.